\documentclass[11pt,twoside]{article}\makeatletter \IfFileExists{xcolor.sty}% {\RequirePackage{xcolor}}% {\RequirePackage{color}} \usepackage{colortbl} \usepackage{wrapfig} \usepackage{ifxetex} \ifxetex \usepackage{fontspec} \usepackage{xunicode} \catcode`⃥=\active \def⃥{\textbackslash} \catcode`❴=\active \def❴{\{} \catcode`❵=\active \def❵{\}} \def\textJapanese{\fontspec{Noto Sans CJK JP}} \def\textChinese{\fontspec{Noto Sans CJK SC}} \def\textKorean{\fontspec{Noto Sans CJK KR}} \setmonofont{DejaVu Sans Mono} \else \IfFileExists{utf8x.def}% {\usepackage[utf8x]{inputenc} \PrerenderUnicode{–} }% {\usepackage[utf8]{inputenc}} \usepackage[english]{babel} \usepackage[T1]{fontenc} \usepackage{float} \usepackage[]{ucs} \uc@dclc{8421}{default}{\textbackslash } \uc@dclc{10100}{default}{\{} \uc@dclc{10101}{default}{\}} \uc@dclc{8491}{default}{\AA{}} \uc@dclc{8239}{default}{\,} \uc@dclc{20154}{default}{ } \uc@dclc{10148}{default}{>} \def\textschwa{\rotatebox{-90}{e}} \def\textJapanese{} \def\textChinese{} \IfFileExists{tipa.sty}{\usepackage{tipa}}{} \fi \def\exampleFont{\ttfamily\small} \DeclareTextSymbol{\textpi}{OML}{25} \usepackage{relsize} \RequirePackage{array} \def\@testpach{\@chclass \ifnum \@lastchclass=6 \@ne \@chnum \@ne \else \ifnum \@lastchclass=7 5 \else \ifnum \@lastchclass=8 \tw@ \else \ifnum \@lastchclass=9 \thr@@ \else \z@ \ifnum \@lastchclass = 10 \else \edef\@nextchar{\expandafter\string\@nextchar}% \@chnum \if \@nextchar c\z@ \else \if \@nextchar l\@ne \else \if \@nextchar r\tw@ \else \z@ \@chclass \if\@nextchar |\@ne \else \if \@nextchar !6 \else \if \@nextchar @7 \else \if \@nextchar (8 \else \if \@nextchar )9 \else 10 \@chnum \if \@nextchar m\thr@@\else \if \@nextchar p4 \else \if \@nextchar b5 \else \z@ \@chclass \z@ \@preamerr \z@ \fi \fi \fi \fi \fi \fi \fi \fi \fi \fi \fi \fi \fi \fi \fi \fi} \gdef\arraybackslash{\let\\=\@arraycr} \def\@textsubscript#1{{\m@th\ensuremath{_{\mbox{\fontsize\sf@size\z@#1}}}}} \def\Panel#1#2#3#4{\multicolumn{#3}{){\columncolor{#2}}#4}{#1}} \def\abbr{} \def\corr{} \def\expan{} \def\gap{} \def\orig{} \def\reg{} \def\ref{} \def\sic{} \def\persName{}\def\name{} \def\placeName{} \def\orgName{} \def\textcal#1{{\fontspec{Lucida Calligraphy}#1}} \def\textgothic#1{{\fontspec{Lucida Blackletter}#1}} \def\textlarge#1{{\large #1}} \def\textoverbar#1{\ensuremath{\overline{#1}}} \def\textquoted#1{‘#1’} \def\textsmall#1{{\small #1}} \def\textsubscript#1{\@textsubscript{\selectfont#1}} \def\textxi{\ensuremath{\xi}} \def\titlem{\itshape} \newenvironment{biblfree}{}{\ifvmode\par\fi } \newenvironment{bibl}{}{} \newenvironment{byline}{\vskip6pt\itshape\fontsize{16pt}{18pt}\selectfont}{\par } \newenvironment{citbibl}{}{\ifvmode\par\fi } \newenvironment{docAuthor}{\ifvmode\vskip4pt\fontsize{16pt}{18pt}\selectfont\fi\itshape}{\ifvmode\par\fi } \newenvironment{docDate}{}{\ifvmode\par\fi } \newenvironment{docImprint}{\vskip 6pt}{\ifvmode\par\fi } \newenvironment{docTitle}{\vskip6pt\bfseries\fontsize{22pt}{25pt}\selectfont}{\par } \newenvironment{msHead}{\vskip 6pt}{\par} \newenvironment{msItem}{\vskip 6pt}{\par} \newenvironment{rubric}{}{} \newenvironment{titlePart}{}{\par } \newcolumntype{L}[1]{){\raggedright\arraybackslash}p{#1}} \newcolumntype{C}[1]{){\centering\arraybackslash}p{#1}} \newcolumntype{R}[1]{){\raggedleft\arraybackslash}p{#1}} \newcolumntype{P}[1]{){\arraybackslash}p{#1}} \newcolumntype{B}[1]{){\arraybackslash}b{#1}} \newcolumntype{M}[1]{){\arraybackslash}m{#1}} \definecolor{label}{gray}{0.75} \def\unusedattribute#1{\sout{\textcolor{label}{#1}}} \DeclareRobustCommand*{\xref}{\hyper@normalise\xref@} \def\xref@#1#2{\hyper@linkurl{#2}{#1}} \begingroup \catcode`\_=\active \gdef_#1{\ensuremath{\sb{\mathrm{#1}}}} \endgroup \mathcode`\_=\string"8000 \catcode`\_=12\relax \usepackage[a4paper,twoside,lmargin=1in,rmargin=1in,tmargin=1in,bmargin=1in,marginparwidth=0.75in]{geometry} \usepackage{framed} \definecolor{shadecolor}{gray}{0.95} \usepackage{longtable} \usepackage[normalem]{ulem} \usepackage{fancyvrb} \usepackage{fancyhdr} \usepackage{graphicx} \usepackage{marginnote} \renewcommand{\@cite}[1]{#1} \renewcommand*{\marginfont}{\itshape\footnotesize} \def\Gin@extensions{.pdf,.png,.jpg,.mps,.tif} \pagestyle{fancy} \usepackage[pdftitle={Hair Growth Promoting Potential of Consciousness Energy Healing Treatment in Human Dermal Papilla Cells}, pdfauthor={}]{hyperref} \hyperbaseurl{} \paperwidth210mm \paperheight297mm \def\@pnumwidth{1.55em} \def\@tocrmarg {2.55em} \def\@dotsep{4.5} \setcounter{tocdepth}{3} \clubpenalty=8000 \emergencystretch 3em \hbadness=4000 \hyphenpenalty=400 \pretolerance=750 \tolerance=2000 \vbadness=4000 \widowpenalty=10000 \renewcommand\section{\@startsection {section}{1}{\z@}% {-1.75ex \@plus -0.5ex \@minus -.2ex}% {0.5ex \@plus .2ex}% {\reset@font\Large\bfseries}} \renewcommand\subsection{\@startsection{subsection}{2}{\z@}% {-1.75ex\@plus -0.5ex \@minus- .2ex}% {0.5ex \@plus .2ex}% {\reset@font\Large}} \renewcommand\subsubsection{\@startsection{subsubsection}{3}{\z@}% {-1.5ex\@plus -0.35ex \@minus -.2ex}% {0.5ex \@plus .2ex}% {\reset@font\large}} \renewcommand\paragraph{\@startsection{paragraph}{4}{\z@}% {-1ex \@plus-0.35ex \@minus -0.2ex}% {0.5ex \@plus .2ex}% {\reset@font\normalsize}} \renewcommand\subparagraph{\@startsection{subparagraph}{5}{\parindent}% {1.5ex \@plus1ex \@minus .2ex}% {-1em}% {\reset@font\normalsize\bfseries}} \def\l@section#1#2{\addpenalty{\@secpenalty} \addvspace{1.0em plus 1pt} \@tempdima 1.5em \begingroup \parindent \z@ \rightskip \@pnumwidth \parfillskip -\@pnumwidth \bfseries \leavevmode #1\hfil \hbox to\@pnumwidth{\hss #2}\par \endgroup} \def\l@subsection{\@dottedtocline{2}{1.5em}{2.3em}} \def\l@subsubsection{\@dottedtocline{3}{3.8em}{3.2em}} \def\l@paragraph{\@dottedtocline{4}{7.0em}{4.1em}} \def\l@subparagraph{\@dottedtocline{5}{10em}{5em}} \@ifundefined{c@section}{\newcounter{section}}{} \@ifundefined{c@chapter}{\newcounter{chapter}}{} \newif\if@mainmatter \@mainmattertrue \def\chaptername{Chapter} \def\frontmatter{% \pagenumbering{roman} \def\thechapter{\@roman\c@chapter} \def\theHchapter{\roman{chapter}} \def\thesection{\@roman\c@section} \def\theHsection{\roman{section}} \def\@chapapp{}% } \def\mainmatter{% \cleardoublepage \def\thechapter{\@arabic\c@chapter} \setcounter{chapter}{0} \setcounter{section}{0} \pagenumbering{arabic} \setcounter{secnumdepth}{6} \def\@chapapp{\chaptername}% \def\theHchapter{\arabic{chapter}} \def\thesection{\@arabic\c@section} \def\theHsection{\arabic{section}} } \def\backmatter{% \cleardoublepage \setcounter{chapter}{0} \setcounter{section}{0} \setcounter{secnumdepth}{2} \def\@chapapp{\appendixname}% \def\thechapter{\@Alph\c@chapter} \def\theHchapter{\Alph{chapter}} \appendix } \newenvironment{bibitemlist}[1]{% \list{\@biblabel{\@arabic\c@enumiv}}% {\settowidth\labelwidth{\@biblabel{#1}}% \leftmargin\labelwidth \advance\leftmargin\labelsep \@openbib@code \usecounter{enumiv}% \let\p@enumiv\@empty \renewcommand\theenumiv{\@arabic\c@enumiv}% }% \sloppy \clubpenalty4000 \@clubpenalty \clubpenalty \widowpenalty4000% \sfcode`\.\@m}% {\def\@noitemerr {\@latex@warning{Empty `bibitemlist' environment}}% \endlist} \def\tableofcontents{\section*{\contentsname}\@starttoc{toc}} \parskip0pt \parindent1em \def\Panel#1#2#3#4{\multicolumn{#3}{){\columncolor{#2}}#4}{#1}} \newenvironment{reflist}{% \begin{raggedright}\begin{list}{} {% \setlength{\topsep}{0pt}% \setlength{\rightmargin}{0.25in}% \setlength{\itemsep}{0pt}% \setlength{\itemindent}{0pt}% \setlength{\parskip}{0pt}% \setlength{\parsep}{2pt}% \def\makelabel##1{\itshape ##1}}% } {\end{list}\end{raggedright}} \newenvironment{sansreflist}{% \begin{raggedright}\begin{list}{} {% \setlength{\topsep}{0pt}% \setlength{\rightmargin}{0.25in}% \setlength{\itemindent}{0pt}% \setlength{\parskip}{0pt}% \setlength{\itemsep}{0pt}% \setlength{\parsep}{2pt}% \def\makelabel##1{\upshape ##1}}% } {\end{list}\end{raggedright}} \newenvironment{specHead}[2]% {\vspace{20pt}\hrule\vspace{10pt}% \phantomsection\label{#1}\markright{#2}% \pdfbookmark[2]{#2}{#1}% \hspace{-0.75in}{\bfseries\fontsize{16pt}{18pt}\selectfont#2}% }{} \def\TheFullDate{2018 2018-01-15 (revised: 15 Year 2018 15 January 2018)} \def\TheID{\makeatother } \def\TheDate{2018 2018-01-15} \title{Hair Growth Promoting Potential of Consciousness Energy Healing Treatment in Human Dermal Papilla Cells} \author{}\makeatletter \makeatletter \newcommand*{\cleartoleftpage}{% \clearpage \if@twoside \ifodd\c@page \hbox{}\newpage \if@twocolumn \hbox{}\newpage \fi \fi \fi } \makeatother \makeatletter \thispagestyle{empty} \markright{\@title}\markboth{\@title}{\@author} \renewcommand\small{\@setfontsize\small{9pt}{11pt}\abovedisplayskip 8.5\p@ plus3\p@ minus4\p@ \belowdisplayskip \abovedisplayskip \abovedisplayshortskip \z@ plus2\p@ \belowdisplayshortskip 4\p@ plus2\p@ minus2\p@ \def\@listi{\leftmargin\leftmargini \topsep 2\p@ plus1\p@ minus1\p@ \parsep 2\p@ plus\p@ minus\p@ \itemsep 1pt} } \makeatother \fvset{frame=single,numberblanklines=false,xleftmargin=5mm,xrightmargin=5mm} \fancyhf{} \setlength{\headheight}{14pt} \fancyhead[LE]{\bfseries\leftmark} \fancyhead[RO]{\bfseries\rightmark} \fancyfoot[RO]{} \fancyfoot[CO]{\thepage} \fancyfoot[LO]{\TheID} \fancyfoot[LE]{} \fancyfoot[CE]{\thepage} \fancyfoot[RE]{\TheID} \hypersetup{citebordercolor=0.75 0.75 0.75,linkbordercolor=0.75 0.75 0.75,urlbordercolor=0.75 0.75 0.75,bookmarksnumbered=true} \fancypagestyle{plain}{\fancyhead{}\renewcommand{\headrulewidth}{0pt}} \date{} \usepackage{authblk} \providecommand{\keywords}[1] { \footnotesize \textbf{\textit{Index terms---}} #1 } \usepackage{graphicx,xcolor} \definecolor{GJBlue}{HTML}{273B81} \definecolor{GJLightBlue}{HTML}{0A9DD9} \definecolor{GJMediumGrey}{HTML}{6D6E70} \definecolor{GJLightGrey}{HTML}{929497} \renewenvironment{abstract}{% \setlength{\parindent}{0pt}\raggedright \textcolor{GJMediumGrey}{\rule{\textwidth}{2pt}} \vskip16pt \textcolor{GJBlue}{\large\bfseries\abstractname\space} }{% \vskip8pt \textcolor{GJMediumGrey}{\rule{\textwidth}{2pt}} \vskip16pt } \usepackage[absolute,overlay]{textpos} \makeatother \usepackage{lineno} \linenumbers \begin{document} \author[1]{Alice Branton} \author[2]{Snehasis Jana} \renewcommand\Authands{ and } \date{\small \em Received: 15 December 2017 Accepted: 1 January 2018 Published: 15 January 2018} \maketitle \begin{abstract} Alopecia is a common disorder related to hair fall, observed in all age?s peoples around the world. Although several medical approaches are available, however those are insufficient to mitigate or symptomatic relief from these types anomalies. Hence, it is highly essential to establish an alternative treatment strategy to increase hair proliferation. For this context, the current experiment was conducted to investigate the potential of the Consciousness Energy Healing (The Trivedi Effect®) Treatment to the test items (DMEM) in human follicular dermal papilla culture cells for the assessment of hair cell growth and development. The test item was divided into two parts. One part was denoted as the untreated DMEM group without any Biofield Energy Treatment, while the other part was defined as the Biofield Energy Treated DMEM group, which received the Biofield Energy Healing Treatment by a renowned Biofield Energy Healer, Alice Branton. The experimental results showed that cell proliferation was significantly increased by 219.30% in the Biofield Energy Treated DMEM group as compared to the untreated DMEM group. The results demonstrated that the Biofield Energy Healing Treatment significantly increased the proliferation of human hair follicle dermal papilla cells. Therefore, the Consciousness Energy Healing (The Trivedi Effect®) Treatment could be useful as a hair growth enhancer against different skin injuries like actinic keratosis, necrotizing fasciitis, sebaceous cysts, diaper rash, decubitus ulcer and hair-related disorders like androgenetic alopecia, telogen effluvium, trichodystrophy, alopecia areata, etc. \end{abstract} \keywords{consciousness energy healing, the trivedi effect®, dermal papilla cells, skin health, hair health, alopecia.} \begin{textblock*}{18cm}(1cm,1cm) % {block width} (coords) \textcolor{GJBlue}{\LARGE Global Journals \LaTeX\ JournalKaleidoscope\texttrademark} \end{textblock*} \begin{textblock*}{18cm}(1.4cm,1.5cm) % {block width} (coords) \textcolor{GJBlue}{\footnotesize \\ Artificial Intelligence formulated this projection for compatibility purposes from the original article published at Global Journals. However, this technology is currently in beta. \emph{Therefore, kindly ignore odd layouts, missed formulae, text, tables, or figures.}} \end{textblock*} \let\tabcellsep& \section[{Introduction}]{Introduction}\par he hair follicle consists of mainly two types of components such as epithelial components that included the matrix and outer root sheath, and the dermal components, which included the dermal papilla and the connective tissue sheath \hyperref[b0]{[1]} . There were three distinct stages of hair growth, which occurs during cellular proliferation like an active phase (anagen), an intermediate regressive (catagen), and a resting phase (telogen) \hyperref[b1]{[2,}\hyperref[b2]{3]} . Literature explored that generally loss of 50-100 hairs per day considered as hair fall disorders like alopecia. Modern trends of fast globalization and indiscriminate grow of industrialization led to the sacral therapy. Human Biofield Energy has subtle energy that can work effectively \hyperref[b10]{[12]} . CAM therapies have been practised worldwide with reported clinical benefits in different health disease profiles \hyperref[b11]{[13]} . This energy can be harnessed and transmitted by the experts into living and non-living things via the process of Biofield Energy II. \section[{Materials and Methods}]{Materials and Methods} \section[{a) Chemicals and Reagents}]{a) Chemicals and Reagents}\par Dulbecco's Modified Eagle Medium (DMEM) and fetal bovine serum (FBS) were obtained from Gibco, India. Minoxidil sulphate (positive control) was purchased from Clearsynth Labs Ltd., Mumbai. Antibiotics solution (penicillin-streptomycin) was \section[{b) BrdU Incorporation Cell Proliferation Assay in HFDPCs}]{b) BrdU Incorporation Cell Proliferation Assay in HFDPCs}\par The human follicular dermal papilla cells (HFDPCs) in DMEM supplemented with 10\% FBS were counted using a hemocytometer and a single cell suspension was prepared. The single cell suspension was seeded at a density of 800 cells/well in a fresh DMEM supplemented with 10\% FBS in 96-well plates. hours of incubation, the medium was replaced with a fresh DMEM supplemented with 0.1\% FBS. Further, after 24 hours, cells were treated with the test items and positive control (minoxidil sulphate). After incubation for 48 hours, the effect of the test items on cell proliferation was assessed by bromodeoxyuridine (BrdU) incorporation using colorimetric ELISA kit. For that, 10 µL of BrdU solution was added per well and the cells were incubated for 90 minutes at 37ºC. After incubation, the medium was removed from each well by gentle pipetting. About 200 µL of a FixDenat solution was added to each well. After incubation, cells were incubated for 30 minutes at room temperature (RT) (15-25ºC). The FixDenat solution was removed by gentle pipetting. After incubation, 100 µL of anti-BrdU-POD (peroxidase) solution was added to each well. Then, the cells were incubated for 90 minutes at RT (15-25ºC). After incubation, the anti-BrdU-POD solution was removed by gentle pipetting. Each well was washed 3 times using 200 µL of washing solution. About 100 µL of substrate solution was added to each well. Cells were incubated for 30 minutes at RT (15-25ºC). After incubation, the absorbance of each well was measured at 370 nm.\par Cellular proliferation was determined as following Equation ( \hyperref[formula_0]{1}):\% ???????????????? ?????????????????????????? = \{(?? ? ??)/??\} ?? 100\textbf{(1)}\par Where, A = OD of Untreated DMEM wells B = OD of cells treated with the test item / positive control. \section[{c) Experimental Design}]{c) Experimental Design}\par The experimental groups composed of group 1 (G-I) with DMEM medium defined as the untreated DMEM group. Group 2 (G-II) contained positive control (minoxidil sulphate) at various concentrations. Further, group 3 (G-III) included the Biofield Energy Treated DMEM group. \section[{d) Biofield Energy Healing Strategy}]{d) Biofield Energy Healing Strategy}\par The test item, DMEM was divided into two parts. First part did not receive any sort of treatment and defined as the untreated DMEM group. The second part was treated with the Biofield Energy Treatment by a Alice Branton remotely for \textasciitilde 5 minutes under laboratory conditions and coded as the Biofield Energy Treated DMEM group. Healer in this study never visited the laboratory in person, nor had any contact with the test items (DMEM medium). Further, the untreated DMEM group was treated with a "sham" healer for comparative purposes. The "sham" healer did not have any knowledge about the Biofield Energy Treatment. After that, the Biofield Energy Treated and untreated test items were kept in similar sealed conditions for experimental study. \section[{e) Statistical Analysis}]{e) Statistical Analysis}\par All the values were represented as Mean ± SEM (standard error of mean) of three independent experiments. The statistical analysis was performed using SigmaPlot statistical software (v11.0). For two multiple group comparison, one-way analysis of variance (ANOVA) was used followed by post-hoc analysis by Dunnett's test. Statistically significant values were set at the level of p?0.05.\par Healing. The Trivedi Effect ® -Consciousness Energy Healing Treatment has been reported with a significant revolution in the physicochemical properties of metals, chemicals, ceramics, and polymers \hyperref[b12]{[14]}\hyperref[b13]{[15]}\hyperref[b14]{[16]} , improved agricultural crop yield, productivity, and quality \hyperref[b15]{[17,}\hyperref[b16]{18]} , transformed antimicrobial characteristics \hyperref[b17]{[19]}\hyperref[b18]{[20]}\hyperref[b21]{[21]} , biotechnology \hyperref[b22]{[22,}\hyperref[b23]{23]} , improved bioavailability \hyperref[b24]{[24]}\hyperref[b25]{[25]}\hyperref[b26]{[26]} , skin health \hyperref[b27]{[27,}\hyperref[b28]{28]} , nutraceuticals \hyperref[b29]{[29,}\hyperref[b30]{30]} , cancer research \hyperref[b31]{[31,}\hyperref[b32]{32]} , bone health \hyperref[b33]{[33]}\hyperref[b34]{[34]}\hyperref[b35]{[35]} , human health and wellness. Considering the promising benefits of an alternative natural therapies-based literature information and importance of Biofield Energy Healing Treatment on various fields, the authors sought to evaluate the impact of the Biofield Energy Treatment (The Trivedi Effect ® ) on the test item (DMEM) for hair cells growth activity using standard assay in human follicular dermal papilla cells. procured from HiMedia, India. Other chemicals used in this study were analytical grade obtained from India.\par Then, the cells were incubated in a CO 2 incubator for 24 hours at 37°C, 5\%CO 2 , and 95\% humidity. After 24 renowned Biofield Energy Healer (The Trivedi Effect ® ), groups comparison student's t-test was used. For III. \section[{Results and Discussion}]{Results and Discussion} \section[{a) BrdU Incorporated Cell Proliferation of Dermal Papilla Cells}]{a) BrdU Incorporated Cell Proliferation of Dermal Papilla Cells}\par The effect of the test item son Biofield Energy Treatment and the percent of cellular proliferation of DPCs is presented in Figure \hyperref[fig_0]{1}. The immortalized human follicular dermal papilla cells suspension were treated with the positive control and test item (DMEM). Topical application of minoxidil is a well-established therapeutic for various types of hair growth-related disorders like alopecia \hyperref[b36]{[36]} . The untreated DMEM group exhibited 100\% cells proliferation of DPCs. Additionally, the positive control, minoxidil showed 68.57\%, 187.14\% (p?0.001), and 230.95\% (p?0.001) increase the cellular proliferation of DPCs at 0.001, 0.01, and 0.1 µM, respectively in a concentration-dependent manner compared to the untreated DMEM group. Moreover, the percent proliferation of DPCs was significantly (p?0.001) increased by 219.30\% in the Biofield Energy Treated DMEM group with respect to the untreated DMEM (Figure \hyperref[fig_0]{1}). For the study of hair follicle biology, human hair growth in vitro model is used as a prototype \hyperref[b37]{[37]} . Hair follicles undergo different cycles of growth (anagen), regression (catagen), quiescence (telogen), and regeneration \hyperref[b38]{[38]} . The current experimental results demonstrated that Biofield Energy Treatment significantly increased the proliferation of dermal papilla cells (DPCs). Further, DPCs are responsible for the regulation of hair follicles development and periodic regeneration \hyperref[b4]{[5,}\hyperref[b36]{36,}\hyperref[b39]{39,}\hyperref[b40]{40]} . Also, the DPCs can generate a signal that regulates the behaviour of keratinocytes in the follicle during the hair cycle \hyperref[b41]{[41,}\hyperref[b42]{42]} . Apart from this, Wnt/?-catenin signaling pathway plays a critical role to initiate generation of hair follicle via stimulation of keratinocytes \hyperref[b43]{[43,}\hyperref[b44]{44]} . Based on the literature and findings of this study, it is assumed that the increment of DPCs The representative photo images signified the intensity of proliferative DPCs after treatment with the Biofield Energy Treated test item (DMEM) in HFDPCs (Figure 2). Overall, data suggested that the Biofield Energy Treatment significantly improved the growth and proliferation of human dermal papilla cells, which is due to the Biofield Energy Healing (The Trivedi Effect ® ). Based on that it is concluded that the Consciousness Energy Therapy could be beneficial to maintain a steady-state proliferation of hair follicles. The study findings was observed that the Biofield Energy Treated test item (DMEM) group showed a significant (p?0.001)increase the percent of dermal papilla cells (DPCs) by 219.30\% in human follicular dermal papilla cells (HFDPCs) in vitro. In conclusion, The Trivedi Effect ® -Consciousness Energy Healing Treatment might act as a hair growth promoter, and it can be used as a complementary and alternative treatment for the prevention of various types of skin and hair-related disorders viz. necrotizing fasciitis, actinic keratosis, sebaceous cysts, diaper rash, decubitus ulcer, androgenetic alopecia, telogen effluvium, trichodystrophy, alopecia areata, etc. Besides, it could be useful to improve cell-to-cell communication, normal cell growth, cell differentiation, neurotransmission, cell cycling and proliferation, hormonal balance, skin health, immune and cardiovascular functions. Moreover, it can also be utilized in organ transplants (i.e., kidney transplants, liver transplants and heart transplants), hormonal imbalance, aging, and various immune-related disease conditions such as Ulcerative Colitis (UC), Alzheimer's Disease (AD), Dermatitis, Irritable Bowel Syndrome (IBS), Asthma, Hashimoto Thyroiditis, Pernicious Anemia, Sjogren Syndrome, Multiple Sclerosis, Aplastic Anemia, Hepatitis, Diverticulitis, Graves' Disease, Dermatomyositis, Diabetes, Myasthenia Gravis, Parkinson's Disease, Atherosclerosis, Systemic Lupus Erythematosus (SLE), stress, etc. with a safe therapeutic index to improve overall health and Quality of Life.\begin{figure}[htbp] \noindent\textbf{1}\includegraphics[]{image-2.png} \caption{\label{fig_0}Fig. 1 :}\end{figure} \begin{figure}[htbp] \noindent\textbf{}\includegraphics[]{image-3.png} \caption{\label{fig_1}±}\end{figure} \backmatter \subsection[{Acknowledgements}]{Acknowledgements}\par Authors gratefully acknowledged to Trivedi Global, Inc., Trivedi Science, Trivedi testimonials and Trivedi master wellness for their support. Also, authors are thankful for the support of Dabur Research Foundation for conducting this study. \begin{bibitemlist}{1} \bibitem[FDA. ()]{b7}\label{b7} \textit{}, \textit{Clin Pharm} FDA. (ed.) 1988. 7 p. . \bibitem[Enshell-Seijffers et al.]{b38}\label{b38} ‘2010) ?-catenin activity in the dermal papilla regulates morphogenesis and regeneration of hair’. D Enshell-Seijffers , C Lindon , M Kashiwagi , B A Morgan . \textit{Dev Cell} 18 p. . \bibitem[Kim]{b3}\label{b3} ‘A (2016) In vivo and in vitro hair growth promotion effects of extract from Glycine soja Siebold et Zucc’. Yang J C Kim , B . \textit{J Appl Biol Chem} 59 p. . \bibitem[Trivedi et al. ()]{b29}\label{b29} ‘A Systematic study of the biofield energy healing treatment on physicochemical, thermal, structural, and behavioral properties of magnesium gluconate’. M K Trivedi , A Branton , D Trivedi , G Nayak , W D Plikerd . \textit{International Journal of Bioorganic Chemistry} 2017. 2 p. . \bibitem[Trivedi and Tallapragada ()]{b12}\label{b12} ‘A transcendental to changing metal powder characteristics’. M K Trivedi , R M Tallapragada . \textit{Met Powder Rep} 2008. 63 p. 31. \bibitem[Trivedi et al. ()]{b21}\label{b21} ‘An impact of biofield treatment: Antimy cobacterial susceptibility potential using BACTEC 460/MGIT-TB System’. M K Trivedi , S Patil , H Shettigar , MondalS C , JanaS . \textit{Mycobact Dis} 2015. 5 p. 189. \bibitem[Stutheit et al. ()]{b35}\label{b35} ‘Biofield energy treated vitamin D3: Therapeutic implication on bone health using osteoblasts cells’. M E Stutheit , K Trivedi , A Branton , D Trivedi , G Nayak . \textit{American Journal of Life Sciences} 2018. 6 p. . \bibitem[Trivedi et al. ()]{b30}\label{b30} ‘Chromatographic and spectroscopic characterization of the consciousness energy healing treated Withania Somnifera (ashwagandha) root extract’. M K Trivedi , A Branton , D Trivedi , G Nayak , W D Plikerd . \textit{European Journal of Biophysics} 2017. 5 p. . \bibitem[Jain et al. ()]{b10}\label{b10} ‘Clinical studies of biofield therapies: Summary, methodological challenges, and recommendations’. S Jain , R Hammerschlag , P Mills , L Cohen , R Krieger . \textit{Glob Adv Health Med} 2015. 4 p. . \bibitem[Singh et al. ()]{b28}\label{b28} ‘Consciousness energy healing treatment based herbomineral formulation: A safe and effective approach for skin health’. J Singh , M K Trivedi , A Branton , D Trivedi , G Nayak . \textit{American Journal of Pharmacology and Phytotherapy} 2017. 2 p. . \bibitem[Stenn and Paus ()]{b4}\label{b4} ‘Controls of hair follicle cycling’. K S Stenn , R Paus . \textit{Physiol Rev} 2001. 81 p. . \bibitem[Mcelwee et al. ()]{b42}\label{b42} ‘Cultured peribulbar dermal sheath cells can induce hair follicle development and contribute to the dermal sheath and dermal papilla’. K J Mcelwee , S Kissling , E Wenzel , A Huth , R Hoffmann . \textit{J Invest} 2003. 121 p. . \bibitem[Hoffmann and Happle ()]{b1}\label{b1} ‘Current understanding of androgenetic alopecia. Part II: Clinical aspects and treatment’. R Hoffmann , R Happle . \textit{Eur J Dermatol} 2000. 10 p. . \bibitem[Lowry et al. ()]{b43}\label{b43} ‘Defining the impact of betacatenin / TCF transactivation on epithelial stem cells’. W E Lowry , C Blanpain , J A Nowak , G Guasch , L Lewis . \textit{Genes Dev} 2005. 19 p. . \bibitem[Trivedi et al. ()]{b14}\label{b14} ‘Effect of biofield energy treatment on physical and structural properties of calcium carbide and praseodymium oxide’. M K Trivedi , G Nayak , S Patil , R M Tallapragada , O Latiyal . \textit{International Journal of Materials Science and Applications} 2015. 4 p. . \bibitem[Nayak and Altekar ()]{b23}\label{b23} ‘Effect of biofield treatment on plant growth and adaptation’. G Nayak , N Altekar . \textit{J Environ Health Sci} 2015. 1 p. . \bibitem[Branton and Jana ()]{b26}\label{b26} ‘Effect of The biofield energy healing treatment on the pharmacokinetics of 25-hydroxyvitamin D3 [25(OH)D3] in rats after a single oral dose of vitamin D3’. A Branton , S Jana . \textit{American Journal of Pharmacology and Phytotherapy} 2017. 2 p. . \bibitem[Choi et al. ()]{b40}\label{b40} ‘Effects of glucocorticoid on human dermal papilla cells in vitro’. S J Choi , A R Cho , Jo S J Hwang , ST , KimK H . \textit{J Steroid Biochem Mol Biol} 2013. 135 p. . \bibitem[Trivedi et al. ()]{b16}\label{b16} ‘Evaluation of biochemical marker -Glutathione and DNA fingerprinting of biofield energy treated Oryza sativa’. M K Trivedi , A Branton , D Trivedi , G Nayak , S C Mondal . \textit{American Journal of BioScience} 2015. 3 p. . \bibitem[Thakur and Dixit ()]{b5}\label{b5} ‘Hair growth promoting activity of Eclipta alba in male albino rats’. Roy R K Thakur , M Dixit , VK . \textit{Arch Dermatol Res} 2008. 300 p. . \bibitem[Yoon and Kang ()]{b19}\label{b19} ‘Hair growth promoting effect of Zizyphus jujuba essential oil’. J I Yoon , Reza S M Kang , S . \textit{Mangifera indica L.). Journal of Food and Nutrition Sciences} 2010. 48 p. . (Food Chem Toxicol) \bibitem[Philpott et al. ()]{b0}\label{b0} ‘Human hair growth in vitro’. M P Philpott , M R Green , T Kealey . \textit{J Cell Sci} 1990. 97 p. . \bibitem[Inui et al. ()]{b37}\label{b37} ‘Identification of androgen-inducible TGF-beta1 derived from dermal papilla cells as a key mediator in androgenetic alopecia’. S Inui , Y Fukuzato , T Nakajima , K Yoshikawa , S Itami . \textit{J Investig Dermatol Symp Proc} 2003. 8 p. . \bibitem[Trivedi et al. ()]{b32}\label{b32} ‘In vitro evaluation of biofield treatment on cancer biomarkers involved in endometrial and prostate cancer cell lines’. M K Trivedi , S Patil , H Shettigar , M Gangwar , JanaS . \textit{J Cancer Sci Ther} 2015. 7 p. . \bibitem[Ojeh et al. ()]{b2}\label{b2} ‘In vitro skin models to study epithelial regeneration from the hair follicle’. N Ojeh , B Akgül , M Tomic-Canic , M Philpott , H Navsaria . \textit{PLoS One} 2017. 12 p. e0174389. \bibitem[Ibrahim and Wright ()]{b41}\label{b41} ‘Inductive capacity of irradiated dermal papillae’. L Ibrahim , E A Wright . \textit{Nature} 1977. 265 p. . \bibitem[Anagnos et al. ()]{b33}\label{b33} ‘Influence of biofield treated vitamin D3 on proliferation, differentiation, and maturation of bone-related parameters in MG-63 cell-line’. D Anagnos , K Trivedi , A Branton , D Trivedi , G Nayak . \textit{International Journal of Biomedical Engineering and Clinical Science} 2018. 4 p. . \bibitem[Gao et al. ()]{b39}\label{b39} ‘Laminin-511 is an epithelial message promoting dermal papilla development and function during early hair morphogenesis’. J Gao , M C De Rouen , Chen C H Nguyen , M Nguyen , NT . \textit{Genes Dev} 2008. 22 p. . \bibitem[Ironson et al. ()]{b9}\label{b9} ‘Massage therapy is associated with enhancement of the immune system's cytotoxic capacity’. G Ironson , T Field , F Scafidi , M Hashimoto , M Kumar . \textit{Int J Neurosci} 1996. 84 p. . \bibitem[Choi et al. ()]{b6}\label{b6} ‘Minoxidil promotes hair growth through stimulation of growth factor release from adipose-derived stem cells’. N Choi , S Shin , Song S U Sung , JH . \textit{Int J Mol Sci} 2018. 19 p. 691. \bibitem[of Hepatitis B and C viruses J Antivir Antiretrovir]{b20}\label{b20} ‘of Hepatitis B and C viruses’. \textit{J Antivir Antiretrovir} 7 p. . \bibitem[Kinney et al. ()]{b27}\label{b27} ‘Overall skin health potential of the biofield energy healing based herbomineral formulation using various skin parameters’. J P Kinney , M K Trivedi , A Branton , D Trivedi , G Nayak . \textit{American Journal of Life Sciences} 2017. 5 p. . \bibitem[Trivedi et al. ()]{b22}\label{b22} ‘Phenotypic and biotypic characterization of Klebsiella oxytoca: An impact of biofield treatment’. M K Trivedi , S Patil , H Shettigar , K Bairwa , JanaS . \textit{J Microb Biochem Technol} 2015. 7 p. . \bibitem[Trivedi et al. ()]{b17}\label{b17} ‘Phenotyping and 16S rDNA analysis after biofield treatment on Citrobacter braakii: A urinary pathogen’. M K Trivedi , A Branton , D Trivedi , G Nayak , S Charan . \textit{J Clin Med Genom} 2015. 3 p. 129. \bibitem[Lutgendorf et al. ()]{b8}\label{b8} \textit{Preservation of immune function in cervical cancer patients during chemoradiation using a novel integrative}, S K Lutgendorf , E Mullen-Houser , D Russell , K Degeest , G Jacobson . 2010. \bibitem[Trivedi et al. ()]{b13}\label{b13} ‘Studies of the atomic and crystalline characteristics of ceramic oxide nano powders after bio field treatment’. M K Trivedi , G Nayak , S Patil , R M Tallapragada , O Latiyal . \textit{Ind Eng Manage} 2015. 4 p. 161. \bibitem[Bang et al. ()]{b36}\label{b36} ‘Successful treatment of temporal triangular alopecia with topical minoxidil’. C Y Bang , J W Byun , M J Kang , Yang B H Song , HJ . \textit{Ann Dermatol} 2013. 25 p. . \bibitem[Rubik ()]{b11}\label{b11} ‘The biofield hypothesis: Its biophysical basis and role in medicine’. B Rubik . \textit{J Altern Complement Med} 2002. 8 p. . \bibitem[Branton and Jana ()]{b24}\label{b24} ‘The influence of energy of consciousness healing treatment on low bioavailable resveratrol in male Sprague Dawley rats’. A Branton , S Jana . \textit{International Journal of Clinical and Developmental Anatomy} 2017. 3 p. . \bibitem[Trivedi et al. ()]{b34}\label{b34} ‘The potential benefits of biofield energy treated vitamin D3 on bone mineralization in human bone osteosarcoma cells (MG-63)’. Lee A C Trivedi , K Branton , A Trivedi , D Nayak , G . \textit{International Journal of Nutrition and Food Sciences} 2018. 7 p. . \bibitem[Trivedi et al. ()]{b31}\label{b31} ‘The potential impact of biofield treatment on human brain tumor cells: A time-lapse video microscopy’. M K Trivedi , S Patil , H Shettigar , MondalS C , JanaS . \textit{J Integr Oncol} 2015. 4 p. 141. \bibitem[Branton and Jana ()]{b25}\label{b25} ‘The use of novel and unique biofield energy healing treatment for the improvement of poorly bioavailable compound, berberine in male Sprague Dawley rats’. A Branton , S Jana . \textit{American Journal of Clinical and Experimental Medicine} 2017. 5 p. . \bibitem[Van Mater ()]{b44}\label{b44} ‘Transient activation of beta-catenin signaling in cutaneous keratinocytes is sufficient to trigger the active growth phase of the hair cycle in mice’. D Van Mater , KolligsF T , DlugoszA A , FearonE . \textit{Genes Dev} 2003. 17 p. . \bibitem[Trivedi et al. ()]{b15}\label{b15} M K Trivedi , A Branton , D Trivedi , G Nayak , S C Mondal . \textit{Morphological characterization, qu ality, yield and DNA fingerprinting of biofield energy}, 2015. \bibitem[Trivedi et al. ()]{b18}\label{b18} M K Trivedi , S Patil , H Shettigar , MondalS C , JanaS . \textit{Evaluation of biofield modality on viral load}, 2015. \end{bibitemlist} \end{document}